An intriguing finding was that Aβ42 but not p-tau immunoreactivity significantly increased in CA1-3 hippocampal regions only in patients with DS, with a trend for increased Aβ42 levels in CA1 from patients with AD. This evidence concerns the gene MAPT and Alzheimer disease.